Identification of pancreatic cancer invasion-related proteins by proteomic analysis

Walsh, Naomi; O'Donovan, Norma; Kennedy, Susan; Henry, Michael; Meleady, Paula; Clynes, Martin; Dowling, Paul
January 2009
Proteome Science;2009, Vol. 7, p1
Academic Journal
Background : Markers of pancreatic cancer invasion were investigated in two clonal populations of the cell line, MiaPaCa-2, Clone #3 (high invasion) and Clone #8 (low invasion) using proteomic profiling of an in vitro model of pancreatic cancer. Materials and methods : Using 2D-DIGE followed by MALDI-TOF MS, two clonal sub-populations of the pancreatic cancer cell line, MiaPaCa-2 with high and low invasive capacities were incubated on matrigel 24 hours prior to analysis to stimulate cell-ECM contact and mimic in vivo interaction with the basement membrane. Results : Sixty proteins were identified as being differentially expressed (> 1.2 fold change and p ≤ 0.05) between Clone #3 and Clone #8. Proteins found to have higher abundance levels in the highly invasive Clone #3 compared to the low invasive Clone #8 include members of the chaperone activity proteins and cytoskeleton constituents whereas metabolism-associated and catalytic proteins had lower abundance levels. Differential protein expression levels of ALDH1A1, VIM, STIP1 and KRT18 and GAPDH were confirmed by immunoblot. Using RNAi technology, STIP1 knockdown significantly reduced invasion and proliferation of the highly invasive Clone #3. Knockdown of another target, VIM by siRNA in Clone #3 cells also resulted in decreased invasion abilities of Clone #3. Elevated expression of STIP1 was observed in pancreatic tumour tissue compared to normal pancreas, whereas ALDH1A1 stained at lower levels in pancreatic tumours, as detected by immunohistochemistry. Conclusion : Identification of targets which play a role in the highly invasive phenotype of pancreatic cancer may help to understand the biological behaviour, the rapid progression of this cancer and may be of importance in the development of new therapeutic strategies for pancreatic cancer.


Related Articles

  • Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon. Natarajan, Thanemozhi G.; Kallakury, Bhaskar V.; Sheehan, Christine E.; Bartlett, Margaret B.; Ganesan, Natarajan; Preet, Anju; Ross, Jeffrey S.; FitzGerald, Kevin T. // Cancer Cell International;2010, Vol. 10, p13 

    Background: MLL2, an epigenetic regulator in mammalian cells, mediates histone 3 lysine 4 tri-methylation (H3K4me3) through the formation of a multiprotein complex. MLL2 shares a high degree of structural similarity with MLL, which is frequently disrupted in leukemias via chromosomal...

  • Notch1 Contributes to Chemoresistance to Gemcitabine and Serves as an Unfavorable Prognostic Indicator in Pancreatic Cancer. Du, Xiao; Zhao, Yu-Pei; Zhang, Tai-Ping; Zhou, Li; Chen, Ge; Cui, Quan-Cai; Shi, Jie; Wang, Tian-Xiao; You, Lei; Shu, Hong // World Journal of Surgery;Jul2013, Vol. 37 Issue 7, p1688 

    Background: Pancreatic cancer (PC) carries frequent chemoresistance and extremely dismal prognosis. The underlying mechanisms remain to be further elucidated. We here report the role of Notch1 in gemcitabine resistance and its prognostic significance in PC. Methods: A small interfering RNA...

  • Over-Expression of Deubiquitinating Enzyme USP14 in Lung Adenocarcinoma Promotes Proliferation through the Accumulation of ß-Catenin. Ning Wu; Cong Liu; Chong Bai; Yi-Ping Han; William C. S. Cho; Qiang Li // International Journal of Molecular Sciences;Jun2013, Vol. 14 Issue 6, p10749 

    The deubiquitinating enzyme USP14 has been identified and biochemically studied, but its role in lung cancer remains to be elucidated. The aim of this study was to evaluate the prognostic significance of USP14 in patients with lung adenocarcinoma and to define its role in lung cancer cell...

  • BIRC6 Protein, an Inhibitor of Apoptosis: Role in Survival of Human Prostate Cancer Cells. Low, Christopher G.; Luk, Iris S. U.; Lin, Dong; Fazli, Ladan; Yang, Kuo; Xu, Yong; Gleave, Martin; Gout, Peter W.; Wang, Yuzhuo // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Background: BIRC6 is a member of the Inhibitors of Apoptosis Protein (IAP) family which is thought to protect a variety of cancer cells from apoptosis. The main objective of the present study was to investigate whether BIRC6 plays a role in prostate cancer and could be useful as a novel...

  • Secretome-Based Identification of ULBP2 as a Novel Serum Marker for Pancreatic Cancer Detection. Ya-Ting Chang; Chih-Ching Wu; Yi-Ming Shyr; Tse-Ching Chen; Tsann-Long Hwang; Ta-Sen Yeh; Kai-Ping Chang; Hao-Ping Liu; Yu-Ling Liu; Ming-Hung Tsai; Yu-Sun Chang; Jau-Song Yu // PLoS ONE;2011, Vol. 6 Issue 5, p1 

    Background: To discover novel markers for improving the efficacy of pancreatic cancer (PC) diagnosis, the secretome of two PC cell lines (BxPC-3 and MIA PaCa-2) was profiled. UL16 binding protein 2 (ULBP2), one of the proteins identified in the PC cell secretome, was selected for evaluation as a...

  • Activation of polyamine catabolic enzymes involved in diverse responses against epibrassinolide-induced apoptosis in LNCaP and DU145 prostate cancer cell lines. Obakan, Pinar; Arisan, Elif; Calcabrini, Annarica; Agostinelli, Enzo; Bolkent, Şehnaz; Palavan-Unsal, Narçin // Amino Acids;Mar2014, Vol. 46 Issue 3, p553 

    Epibrassinolide (EBR) is a biologically active compound of the brassinosteroids, steroid-derived plant growth regulator family. Generally, brassinosteroids are known for their cell expansion and cell division-promoting roles. Recently, EBR was shown as a potential apoptotic inducer in various...

  • Validation of Orthopedic Postoperative Pain Assessment Methods for Dogs: A Prospective, Blinded, Randomized, Placebo-Controlled Study. Rialland, Pascale; Authier, Simon; Guillot, Martin; del Castillo, Jérôme R. E.; Veilleux-Lemieux, Daphné3; Frank, Diane; Gauvin, Dominique; Troncy, Eric // PLoS ONE;Nov2012, Vol. 7 Issue 11, Special section p1 

    In the context of translational research, there is growing interest in studying surgical orthopedic pain management approaches that are common to humans and dogs. The validity of postoperative pain assessment methods is uncertain with regards to responsiveness and the potential interference of...

  • Expression of IL-13Rα2 in liver cancer cells and its effect on targeted therapy of liver cancer. Lingling Hou; Juan Du; Jianwei Wang; Yanfeng Liu; Weimin Sun; Yanpeng Zheng; Lishu Zhang; Honggang Hu; Xinxian Dai; Weijun Guan; Yuehui Ma; Tao Hong // Journal of Cancer Research & Clinical Oncology;Jun2010, Vol. 136 Issue 6, p839 

    Liver cancer is the third leading cause of cancer-related deaths globally. The number of liver cancers diagnosed in the world is increasing at an alarming rate. It is of great significance to find the new targets of the tumor cells and specific medicine. This research investigated the expression...

  • In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines. Navo, Marisa A.; Smith, Judith A.; Gaikwad, Anjali; Burke, Thomas; Brown, Jubilee; Ramondetta, Lois M. // Cancer Chemotherapy & Pharmacology;Aug2008, Vol. 62 Issue 3, p483 

    To determine the growth inhibitory effects of mifepristone on endometrial cancer cell growth and evaluate its effect on apoptosis using HEC-1-A and Ishikawa human endometrial cancer cell lines. The human endometrial cancer cell lines, HEC-1-A and Ishikawa, were cultured in vitro. MTT assays were...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics